Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NSE - Delayed Quote INR

Kopran Limited (KOPRAN.NS)

Compare
190.08
+14.85
+(8.47%)
At close: 3:29:58 PM GMT+5:30
Loading Chart for KOPRAN.NS
  • Previous Close 175.23
  • Open 182.99
  • Bid --
  • Ask --
  • Day's Range 182.99 - 192.48
  • 52 Week Range 155.00 - 369.70
  • Volume 561,755
  • Avg. Volume 159,457
  • Market Cap (intraday) 9.19B
  • Beta (5Y Monthly) 0.68
  • PE Ratio (TTM) 19.30
  • EPS (TTM) 9.85
  • Earnings Date May 14, 2025 - May 19, 2025
  • Forward Dividend & Yield 3.00 (1.62%)
  • Ex-Dividend Date Sep 2, 2024
  • 1y Target Est --

Kopran Limited, an integrated pharmaceutical company, engages in the manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-acne, anti-infective, anti-thrombotic, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular. In addition, the company provides drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is based in Mumbai, India.

www.kopran.com

842

Full Time Employees

March 31

Fiscal Year Ends

Recent News: KOPRAN.NS

View More

Performance Overview: KOPRAN.NS

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

KOPRAN.NS
10.25%
S&P BSE SENSEX (^BSESN)
3.82%

1-Year Return

KOPRAN.NS
30.88%
S&P BSE SENSEX (^BSESN)
0.16%

3-Year Return

KOPRAN.NS
38.73%
S&P BSE SENSEX (^BSESN)
27.46%

5-Year Return

KOPRAN.NS
590.84%
S&P BSE SENSEX (^BSESN)
141.20%

Compare To: KOPRAN.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KOPRAN.NS

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    8.47B

  • Enterprise Value

    9.63B

  • Trailing P/E

    17.79

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.32

  • Price/Book (mrq)

    1.70

  • Enterprise Value/Revenue

    1.51

  • Enterprise Value/EBITDA

    11.24

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.38%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    6.43B

  • Net Income Avi to Common (ttm)

    474.95M

  • Diluted EPS (ttm)

    9.85

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    83.05M

  • Total Debt/Equity (mrq)

    24.96%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: KOPRAN.NS

View More

Company Insights: KOPRAN.NS

Research Reports: KOPRAN.NS

View More

People Also Watch